Loading organizations...
Nivelinvest operates as a comprehensive investment firm within Belgium, primarily focusing on private equity to facilitate real estate investment and development projects. Concurrently, it functions as a venture capital provider, extending seed-stage financing to small and medium-sized enterprises. The firm employs adaptable investment strategies and tools to align its capital deployment with the evolving economic fabric of the region.
The exact founding details, including specific founders and the precise inception date for the Belgian entity, are not readily available from public snippets. However, its historical presence within the regional investment landscape suggests a steady evolution and adaptation of its strategies to meet prevailing market demands, indicating a foundation built on sustained engagement with the local economy over time.
The company primarily serves emerging small and medium enterprises seeking early-stage capital, in addition to engaging with various real estate development ventures. Nivelinvest's overarching vision centers on contributing to regional economic vitality by providing crucial investment support and fostering the growth of businesses and key infrastructure.
Nivelinvest has 2 tracked investments across 1 company. The latest tracked deal is $31.4M Debt / Series B in Promethera Biosciences in March 2012.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Mar 28, 2012 | Promethera Biosciences | $31.4M Debt / Series B | — | Atmi, Boehringer Ingelheim, Financière Spin OFF Luxembourgeoise, Life Sciences Research Partners, Mitsui & CO. Global Investment, Sambrinvest, Shire, Sopartec, Sriw, Vesalius Biocapital, Vives Louvain Technology Fund, Walloon Region |
| Nov 9, 2009 | Promethera Biosciences | $8.0M Series A | Vesalius Biocapital | Capital Croissance, Life Sciences Research Partners, LRM, Sopartec, Sriw, Vives Louvain Technology Fund |